Journal of International Oncology ›› 2019, Vol. 46 ›› Issue (2): 109-112.doi: 10.3760/cma.j.issn.1673-422X.2019.02.011
Previous Articles Next Articles
Li Qin, Fu Zhenming
Online:
Published:
Contact:
Supported by:
National Natural Science Foundation of China (81472971, 81773555)
Abstract: Lung cancer has been the most dangerous malignant tumor in the worldwide. Nowadays, for patients with resectable early or local advanced nonsmall cell lung cancer (NSCLC), both domestic and foreign guidelines recommended multidisciplinary treatments like surgery, chemotherapy and radiotherapy. Recent studies have shown that neoadjuvant chemotherapy can significantly improve the prognosis of patients with resectable NSCLC and has better treatment compliance and tolerance.
Key words: Carcinoma, non-small-cell lung, Chemotherapy, adjuvant
Li Qin, Fu Zhenming. Analysis of current status of neoadjuvant chemotherapy for non-small cell lung cancer[J]. Journal of International Oncology, 2019, 46(2): 109-112.
/ Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://gjzlx.sdfmu.edu.cn/EN/10.3760/cma.j.issn.1673-422X.2019.02.011
https://gjzlx.sdfmu.edu.cn/EN/Y2019/V46/I2/109
